Oral placebo capsules

DRUG4 trials

Sponsors

University of British Columbia, Galderma R&D, Liverpool School of Tropical Medicine, University of Oklahoma

Conditions

Diabetic RetinopathyParkinson's DiseaseRosaceaSnakebite

Phase 2

Trial of Oral Community SVMP INhibitors for Snakebite

Not yet recruitingNCT07500233

Liverpool School of Tropical MedicineSnakebite

Start: 2027-01-01End: 2028-12-01Target: 504Updated: 2026-05-12

Phase 4

Oracea Soolantra Association in Participants With Severe Rosacea

CompletedNCT03075891

Galderma R&DRosacea

Start: 2017-07-05End: 2018-02-08Updated: 2021-03-16

Unknown Phase

Trientine Hydrochloride for the Prevention of Macular Edema Associated With Pan-retinal Photocoagulation for Severe Non-proliferative and Proliferative Diabetic Retinopathy

TerminatedNCT01213888

University of British ColumbiaDiabetic Retinopathy

Start: 2010-11-30End: 2013-04-30Updated: 2013-05-03

NAD Supplementation in Parkinson's Disease

Enrolling by invitationNCT07703137

University of OklahomaParkinson's Disease

Start: 2026-08-10End: 2027-07-01Target: 40Updated: 2026-08-12